[In reference to "Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market”]

by Matteo Ferrario, Giovanni Giuliani
Published 2017-09-01

Timely Access to Priority Medicines in Europe

by Enrico Bosone, Giovanni Giuliani, Nicoletta Martone, Anna Ponzianelli, Valeria Viola
Published 2017-01-01

Title not available

by Clement Tournier, Valerie Deroo, Sara Villa, Giovanni Giuliani, Carlo Lucioni, Silvio Mazzi, Roberto Ravasio
Published 2016-07-01

Leveraging EUnetHTA’s conceptual framework to compare HTA decision drivers in France, Italy, and Germany from a manufacturer’s point of view

by Giovanni Giuliani, Frederic Chassagnol, David Traub, Marlene Gyldmark, Ansgar Hebborn, Pierre Ducournau, Jörg Ruof
Published 2018-09-01

Effect of Hemoadsorption for Cytokine Removal in Pneumococcal and Meningococcal Sepsis

by Francesca Leonardis, Viviana De Angelis, Francesca Frisardi, Chiara Pietrafitta, Ivano Riva, Tino Martino Valetti, Valentina Broletti, Gianmariano Marchesi, Lorenza Menato, Roberto Nani, Franco Marson, Mirca Fabbris, Luca Cabrini, Sergio Colombo, Alberto Zangrillo, Carlo Coniglio, Giovanni Gordini, Lucia Stalteri, Giovanni Giuliani, Vittorio Dalmastri, Gaetano La Manna
Published 2018-01-01